Network analysis of toxin production in Clostridioides difficile identifies key metabolic dependencies

Deborah A Powers1, Matthew L Jenior2, Glynis L Kolling2

  • 1Biochemistry and Molecular Genetics, School of Medicine, University of Virginia, Charlottesville, Virginia, United States of America.

Insights

Understanding Clostridioides difficile toxin production requires exploring intracellular metabolic pathways. This study reveals key metabolic dependencies, like arginine and ornithine uptake, that influence toxin levels, offering potential therapeutic targets.

Area of Science:

  • Microbiology
  • Metabolic Engineering
  • Computational Biology

Background:

  • Clostridioides difficile pathogenesis is driven by toxins TcdA and TcdB, causing cell death and inflammation.
  • Extracellular metabolite concentrations can alter toxin production, but intracellular pathways remain poorly understood.

Purpose of the Study:

  • To investigate intracellular metabolic pathways' response to varying nutritional environments and toxin production states in C. difficile.
  • To identify metabolic patterns and dependencies linked to C. difficile toxin production.

Main Methods:

  • Utilized pre-existing genome-scale metabolic models (iCdG709, iCdR703) for C. difficile strains.
  • Integrated transcriptomic data with models using the RIPTiDe algorithm to create contextualized models.
  • Employed Random Forest, flux sampling, shadow pricing, and metabolic transformation algorithm (MTA) for analysis.

Main Results:

  • Identified specific metabolic patterns correlated with toxin production states and nutritional environments.
  • Found active arginine and ornithine uptake in low toxin states, dependent on fatty acid and polymer metabolite pools.
  • Determined model perturbations to shift metabolism from high to low toxin states.

Conclusions:

  • Expanded understanding of C. difficile toxin regulation through intracellular metabolic pathways.
  • Identified key metabolic dependencies that could be targeted to mitigate C. difficile-associated disease severity.